0001685428-20-000001.txt : 20200226 0001685428-20-000001.hdr.sgml : 20200226 20200226164246 ACCESSION NUMBER: 0001685428-20-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200226 DATE AS OF CHANGE: 20200226 EFFECTIVENESS DATE: 20200226 FILER: COMPANY DATA: COMPANY CONFORMED NAME: LumiraDx Ltd CENTRAL INDEX KEY: 0001685428 IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-361422 FILM NUMBER: 20656415 BUSINESS ADDRESS: STREET 1: 3 MORE LONDON RIVERSIDE CITY: LONDON STATE: X0 ZIP: SE1 2AQ BUSINESS PHONE: 011 44 1786 430411 MAIL ADDRESS: STREET 1: 3 MORE LONDON RIVERSIDE CITY: LONDON STATE: X0 ZIP: SE1 2AQ D 1 primary_doc.xml X0708 D LIVE 0001685428 LumiraDx Ltd 3 MORE LONDON RIVERSIDE LONDON X0 UNITED KINGDOM SE1 2AQ 011 44 1786 430411 CAYMAN ISLANDS None None Other Exempted company limited by shares true 2016 Ron Zwanziger c/o LumiraDx Limited 3 More London Riverside London X0 UNITED KINGDOM SE 1 2AQ Executive Officer Director David Scott c/o LumiraDx Limited 3 More London Riverside London X0 UNITED KINGDOM SE 1 2AQ Executive Officer Director Jerry McAleer c/o LumiraDx Limited 3 More London Riverside London X0 UNITED KINGDOM SE 1 2AQ Executive Officer Director David Walton c/o LumiraDx Limited 3 More London Riverside London X0 UNITED KINGDOM SE 1 2AQ Executive Officer Nigel Lindner c/o LumiraDx Limited 3 More London Riverside London X0 UNITED KINGDOM SE1 2AQ Executive Officer Peter Welch c/o LumiraDx Limited 3 More London Riverside London X0 UNITED KINGDOM SE 1 2AQ Executive Officer Veronique Ameye c/o LumiraDx Limited 3 More London Riverside London X0 UNITED KINGDOM SE 1 2AQ Executive Officer Tom Quinlan c/o LumiraDx Limited 3 More London Riverside London X0 UNITED KINGDOM SE 1 2AQ Executive Officer Peter Scheu c/o LumiraDx Limited 3 More London Riverside London X0 UNITED KINGDOM SE 1 2AQ Executive Officer Dorian LeBlanc c/o LumiraDx Limited 3 More London Riverside London X0 UNITED KINGDOM SE 1 2AQ Executive Officer Donald Berwick c/o LumiraDx Limited 3 More London Riverside London X0 UNITED KINGDOM SE 1 2AQ Director Bruce Keogh c/o LumiraDx Limited 3 More London Riverside London X0 UNITED KINGDOM SE 1 2AQ Director Lurene Joseph c/o LumiraDx Limited 3 More London Riverside London X0 UNITED KINGDOM SE 1 2AQ Director Lu Huang c/o LumiraDx Limited 3 More London Riverside London X0 UNITED KINGDOM SE 1 2AQ Director Troyen Brennan c/o LumiraDx Limited 3 More London Riverside London X0 UNITED KINGDOM SE 1 2AQ Director Suresh Vazirani c/o LumiraDx Limited 3 More London Riverside London X0 UNITED KINGDOM SE 1 2AQ Director Other Health Care Decline to Disclose 06b false 2019-10-15 false true false 75000 U.S. Boston Capital Corporation 5251 None None 55 Old Bedford Road Lincoln MA MASSACHUSETTS 01773 SC SOUTH CAROLINA UT UTAH HI HAWAII IL ILLINOIS NY NEW YORK CT CONNECTICUT DC DISTRICT OF COLUMBIA MN MINNESOTA CA CALIFORNIA ME MAINE NH NEW HAMPSHIRE WA WASHINGTON VA VIRGINIA NJ NEW JERSEY TX TEXAS CO COLORADO FL FLORIDA PA PENNSYLVANIA NC NORTH CAROLINA MD MARYLAND MA MASSACHUSETTS false 150000000 75155586 74844414 Amount sold shown in item 13 and number of investors shown in item 14 includes $25,250,000 to 5 non-US investors false 171 2705172 true 0 U.S. Boston Capital Corp. receives an administrative fee and a placement fee based on amount sold. A portion of the fee was paid in convertible notes. 0 false LumiraDx Ltd /s/Dorian LeBlanc Dorian LeBlanc CFO 2020-02-25